Results 121 to 128 of about 1,192 (128)
Some of the next articles are maybe not open access.
Biomarkers for Alzheimer's Disease: Academic, Industry and Regulatory Perspectives
Nature Reviews Drug Discovery, 2010Jamie Toombs +2 more
exaly
Histone Deacetylases as Therapeutic Targets in Neurodegenerative Diseases
Medical Epigenetics, 2016exaly
Amyloid-Beta Solubility in the Treatment of Alzheimer’s Disease
New England Journal of Medicine, 2018M Paul Murphy
exaly
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
New England Journal of Medicine, 2018Eric Siemers +2 more
exaly
Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
New England Journal of Medicine, 1998Richard Mayeux +2 more
exaly
Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
New England Journal of Medicine, 1989Ralph Martins +2 more
exaly
Biomarker Changes During 20 Years Preceding Alzheimer’s Disease
New England Journal of MedicineJianping Jia, Jihui Lyu, Yuye Ning
exaly
Alzheimer's Failure Raises Questions About Disease-Modifying Strategies
Nature Reviews Drug Discovery, 2010exaly

